Episodio – Antiemesis en quimioterapia: el papel clave del receptor NK1 | USMLE Step 1

from USMLE DREAMERS · host USMLE DREAMERS

Paciente con cáncer sometida a quimioterapia altamente emetógena sigue vomitando pese a uso continuo de ondansetrón. En este episodio discutimos cómo funciona el reflejo del vómito y por qué la inhibición del receptor NK1 es esencial para controlar la emesis refractaria inducida por quimioterapia.#USMLE #Step1 #Quimioterapia #Emesis #Ondansetron #NK1 #Aprepitant #USMLEDreamers

What this episode covers

NOW PLAYING

0:00 5:22

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of USMLE DREAMERS?

This episode is 5 minutes long.

When was this USMLE DREAMERS episode published?

This episode was published on November 27, 2025.

What is this episode about?

Can I download this USMLE DREAMERS episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!